ArabFinance: October Pharma (OCPH) recorded a net profit after tax of EGP 119.791 million in 2021, up from EGP 88.258 million in 2020, according to financial statements filed to the Egyptian Exchange (EGX) on Monday.
Net sales surged to EGP 655.036 million in 2021, from EGP 543.397 million in 2020, statements showed.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.